Herantis Pharma Oyj Cash Flow Reinvestment Rate
Latest as of December 2013:
2299.45x
Herantis Pharma Oyj cash flow reinvestment rate. Herantis Pharma Oyj (HRTIS) has a Cash Flow Reinvestment Rate of 2299.45x as of December 2013, reinvesting €421.35K (capex €421.35K ) from operating cash flow of €183.24. See HRTIS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
2299.45x
(Capex + Investments) / Operating CF
Total Reinvested
€421.35K
Capex + Investments
Operating Cash Flow
€183.24
EUR
Capital Expenditures
€421.35K
EUR
Herantis Pharma Oyj Cash Flow Reinvestment Rate by Year (None–None)
Herantis Pharma Oyj cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Herantis Pharma Oyj. For the full cash flow conversion analysis, see Herantis Pharma Oyj operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow